The somatostatin receptor 2 antagonist <sup>64</sup>Cu-NODAGA-JR11 outperforms <sup>64</sup>Cu-DOTA-TATE in a mouse xenograft model.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0195802
- By:
- Publication type:
- Article
Works by Stoykow, Christian
Results: 6
1
2
Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.
- Published in:
- 2018
- By:
- Publication type:
- journal article
3
Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.
- Published in:
- 2018
- By:
- Publication type:
- journal article
4
Performance of <sup>111</sup>In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2062, doi. 10.1007/s00259-018-4094-0
- By:
- Publication type:
- Article
5
Morphologically 'invisible' proinsulin - secreting adenoma detected by Ga-68 Exendin-4 (GLP-1 Receptor) positron emission tomography/CT.
- Published in:
- 2018
- By:
- Publication type:
- journal article
6
Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-0598-2
- By:
- Publication type:
- Article